Article Information
History
- April 5, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 5, 2022 - 20:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shigeki Saito1,*,
- Cheng Han H. Chung1,
- Alex Jacob1,
- Nebil Nuradin1,
- Amy E. Meyer1,
- Toshie Saito3,
- Haoran Yang1,2,4,
- Jay K. Kolls1,2,4,
- Victor J. Thannickal1,
- Yao-Zhong Liu5,# and
- Joseph A. Lasky1,#
- 1Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA
- 2Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA
- 3Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
- 4Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA
- 5Department of Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA
- ↵*Corresponding author Section of Pulmonary Diseases, Critical Care and Environmental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA, Phone: (504) 988-2251; Fax: (504) 988-2144, Address: 1430 Tulane Ave., Box 8509, New Orleans, LA 70112-2699, USA; email: ssaito{at}tulane.edu
↵# contributed equally
Posted April 05, 2022.
Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis (IPF)
